Literature DB >> 8364098

The rne gene and ribonuclease E.

A Miczak1, D Apirion.   

Abstract

The cloned rne+ gene complements temperature sensitive RNase E mutations and directs the synthesis of a polypeptide. In vitro the RNA transcribed from the rne gene directs the synthesis of a number of polypeptides, one of which is identical in size to the in vivo product of the rne gene. A rabbit reticulocyte cell free extract programmed with this RNA produced RNase E activity. Thus, it is evident that the rne gene is the structural gene for RNase E. However, the in vivo product of the cloned RNase E gene is more thermolabile than the chromosomal gene product. When cells containing the rne plasmid were treated with chloramphenicol, the pre-existing RNase E became less heat labile with time. This leads to the suggestion that in the cell RNase E undergoes post-translational modification(s).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364098     DOI: 10.1016/0300-9084(93)90113-7

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  4 in total

1.  Proteins associated with RNase E in a multicomponent ribonucleolytic complex.

Authors:  A Miczak; V R Kaberdin; C L Wei; S Lin-Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

2.  Coincident Hfq binding and RNase E cleavage sites on mRNA and small regulatory RNAs.

Authors:  Isabella Moll; Taras Afonyushkin; Oresta Vytvytska; Vladimir R Kaberdin; Udo Bläsi
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

3.  Both RNase E and RNase III control the stability of sodB mRNA upon translational inhibition by the small regulatory RNA RyhB.

Authors:  Taras Afonyushkin; Branislav Vecerek; Isabella Moll; Udo Bläsi; Vladimir R Kaberdin
Journal:  Nucleic Acids Res       Date:  2005-03-21       Impact factor: 16.971

4.  RNase E-dependent processing stabilizes MicX, a Vibrio cholerae sRNA.

Authors:  Brigid M Davis; Matthew K Waldor
Journal:  Mol Microbiol       Date:  2007-06-21       Impact factor: 3.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.